These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 160445)

  • 1. Interactions between central monoaminergic systems: dopamine-serotonin.
    Roccatagliata G; Albano C; Cocito L; Maffini M
    J Neurol Neurosurg Psychiatry; 1979 Dec; 42(12):1159-62. PubMed ID: 160445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dopamine-serotonin relationship in clozapine response.
    Szymanski S; Lieberman J; Pollack S; Munne R; Safferman A; Kane J; Kronig M; Cooper T
    Psychopharmacology (Berl); 1993; 112(1 Suppl):S85-9. PubMed ID: 7530378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous covariability of dopamine and serotonin metabolites in human cerebrospinal fluid.
    Geracioti TD; Keck PE; Ekhator NN; West SA; Baker DG; Hill KK; Bruce AB; Wortman MD
    Biol Psychiatry; 1998 Aug; 44(3):228-33. PubMed ID: 9693394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid metabolites and precursor amino acids of 5-hydroxytryptamine and dopamine in affective and other psychiatric disorders.
    Korf J; van den Burg W; van den Hoofdakker RH
    Psychiatr Clin (Basel); 1983; 16(1):1-16. PubMed ID: 6189146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central noradrenergic function in man: vanillylmandelic acid in CSF.
    Jimerson DC; Gordon EK; Post RM; Goodwin FK
    Brain Res; 1975 Dec; 99(2):434-9. PubMed ID: 1182564
    [No Abstract]   [Full Text] [Related]  

  • 6. CSF monoamine metabolites in child and adult psychiatric patients. A developmental perspective.
    Leckman JF; Cohen DJ; Shaywitz BA; Caparulo BK; Heninger GR; Bowers MB
    Arch Gen Psychiatry; 1980 Jun; 37(6):677-81. PubMed ID: 6155891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Late chronic dyskinesia from neuroleptic drugs (CSF and pharmacological data) (author's transl)].
    Roccatagliata G; Albano C; Besio G
    Riv Patol Nerv Ment; 1978 Sep; 98(4):228-32. PubMed ID: 33440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between estimated premorbid adjustment and CSF homovanillic acid and 5-hydroxyindoleacetic acid levels.
    Leckman JF; Bowers MB; Sturges JS
    Am J Psychiatry; 1981 Apr; 138(4):472-7. PubMed ID: 6163366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seasonal changes of CSF monoamine metabolites in psychiatric patients: what is the source?
    Csernansky JG; Faull KF; Pfefferbaum A
    Psychiatry Res; 1988 Sep; 25(3):361-3. PubMed ID: 2460883
    [No Abstract]   [Full Text] [Related]  

  • 10. CSF amine metabolites, clinical symptoms, and body movement in psychiatric patients.
    Kirstein L; Bowers MB; Heninger G
    Biol Psychiatry; 1976 Aug; 11(4):421-34. PubMed ID: 963133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low lumbar CSF levels of homovanillic acid and 5-hydroxyindoleacetic acid in multiple system atrophy with autonomic failure.
    Polinsky RJ; Brown RT; Burns RS; Harvey-White J; Kopin IJ
    J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):914-9. PubMed ID: 2462617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age and Gender-Related Changes in Biogenic Amine Metabolites in Cerebrospinal Fluid in Children.
    Kuśmierska K; Szymańska K; Rokicki D; Kotulska K; Jóźwiak S; Sykut-Cegielska J; Mierzewska H; Szczepanik E; Pronicka E; Demkow U
    Adv Exp Med Biol; 2016; 878():73-82. PubMed ID: 26453071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine, noradrenaline and serotonin spinal fluid metabolites in temporal lobe epileptic patients with schizophrenic symptomatology.
    Peters JG
    Eur Neurol; 1979; 18(1):15-8. PubMed ID: 436860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogeny of dopamine and serotonin metabolites in the cerebrospinal fluid of children with neurological disorders.
    Shaywitz BA; Cohen DJ; Leckman JF; Young JG; Bowers MB
    Dev Med Child Neurol; 1980 Dec; 22(6):748-54. PubMed ID: 6161049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
    Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
    Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevated CSF serotonin and dopamine metabolite levels in overweight subjects.
    Markianos M; Evangelopoulos ME; Koutsis G; Sfagos C
    Obesity (Silver Spring); 2013 Jun; 21(6):1139-42. PubMed ID: 23670875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precursors and metabolites of 5-hydroxytryptamine and dopamine in the ventricular cerebrospinal fluid of psychiatric patients.
    Bridges PK; Bartlett JR; Sepping P; Kantamaneni BD; Curzon G
    Psychol Med; 1976 Aug; 6(3):399-405. PubMed ID: 996200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does dantrolene influence central dopamine and serotonin metabolism in the neuroleptic malignant syndrome? A retrospective study.
    Nisijima K; Ishiguro T
    Biol Psychiatry; 1993 Jan; 33(1):45-8. PubMed ID: 7678377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine and serotonin metabolites in rat cerebroventricular fluid following withdrawal of haloperidol or electroshock treatment.
    Barkai AI; Kowalik S; Reches A
    Psychopharmacology (Berl); 1984; 84(3):352-5. PubMed ID: 6083575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.